Morgan Stanley Discount Zert AZN .../ DE000MG6S8B1 /
2024-12-20 6:28:27 PM | Chg.-0.04 | Bid10:00:35 PM | Ask10:00:35 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
56.20EUR | -0.07% | - Bid Size: - |
- Ask Size: - |
AstraZeneca PLC | - USD | 2025-12-30 | Call |
Newsfile Corp
12-21
ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Ac...
Newsfile Corp
12-20
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Inquire About Securities Cla...
Newsfile Corp
12-18
ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Inquire About Securities Cl...
GlobeNewswire
08-13
Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
06-20
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire
05-15
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
05-13
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-08
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
04-01
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire
03-25
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, In...
GlobeNewswire
03-25
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
GlobeNewswire
03-19
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...